Medical ultrasonic contrast agent imaging method and apparatus

2003 ◽  
Vol 113 (6) ◽  
pp. 2971
Author(s):  
Patrick J. Phillips ◽  
Ismayil M. Guracar
Keyword(s):  
Contrast Agent ◽  
Imaging Method ◽  
Ultrasonic Contrast Agent

A Novel Site-Targeted Ultrasonic Contrast Agent With Broad Biomedical Application

Circulation ◽  
1996 ◽  
Vol 94 (12) ◽  
pp. 3334-3340 ◽  
Author(s):  
Gregory M. Lanza ◽  
Kirk D. Wallace ◽  
Michael J. Scott ◽  
William P. Cacheris ◽  
Dana R. Abendschein ◽  
...  
Keyword(s):  
Contrast Agent ◽  
Biomedical Application ◽  
Ultrasonic Contrast Agent

scholarly journals ICAM-1-carrying targeted nano contrast agent for evaluating inflammatory injury in rabbits with atherosclerosis

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Ping Li ◽  
Lin Jin ◽  
Lan Feng ◽  
Yingchun Wang ◽  
Rong Yang
Keyword(s):  
Contrast Agent ◽  
Outer Membrane ◽  
Signal Intensity ◽  
Vascular Wall ◽  
Control Group ◽  
Imaging Method ◽  
Vascular Perfusion ◽  
Inflammatory Injury ◽  
Modeling Group ◽  
Group B

AbstractTo investigate the feasibility of using ICAM-1-targeted nano ultrasonic contrast to evaluate the degree of inflammatory injury at different stages in the abdominal aorta of rabbits with atherosclerosis (AS). Twenty-five experimental rabbits were assigned to five groups: the control group (A); the week-4 after modeling group (B); the week-8 after modeling group (C); the week-12 after modeling group (D); the week-16 after modeling group (E). All groups were given 2D ultrasonography, conventional ultrasonic contrast (SonoVue), and ICAM-1-targeted nano ultrasonic contrast, respectively. Signal intensity of vascular perfusion was evaluated. Signal intensity of ICAM-1-targeted nano ultrasonic contrast was substantially enhanced and prolonged in the vascular wall of the abdominal bubble aorta increased in B, C, D, and E groups (all P < 0.05). A positive linear correlation between intensity and the expression of ICAM-1 (r = 0.895, P < 0.001). The intensity of outer membrane was enhanced from week 4 to week 12, and both the intima-media membrane and outer membrane were enhanced with double-layer parallel echo at week 16, which was in line with the progression of atherosclerotic plaque inflammatory injury. ICAM-1-targeted nano contrast agent would be possibly a novel non-invasive molecular imaging method for plaque inflammatory injury and site high expression of specific adhesion molecules in early atherosclerotic lesions.

scholarly journals In Vivo Quantification of Myocardial Infarction in Mice Using Micro-CT and a Novel Blood Pool Agent

2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Stefan Sawall ◽  
Danielle Franke ◽  
Anne Kirchherr ◽  
Jan Beckendorf ◽  
Jan Kuntz ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Contrast Agent ◽  
Infarct Size ◽  
Blood Pool ◽  
Signal Enhancement ◽  
Imaging Method ◽  
Micro Ct ◽  
Contrast Agent Injection ◽  
Dependent Signal

We herein developed a micro-CT method using the innovative contrast agent ExiTron™ MyoC 8000 to longitudinally monitor cardiac processes in vivo in small animals. Experiments were performed on healthy mice and mice with myocardial infarction inflicted by ligation of the left anterior descending artery. Time-dependent signal enhancement in different tissues of healthy mice was measured and various contrast agent doses were investigated so as to determine the minimum required dose for imaging of the myocardium. Due to its ability to be taken up by healthy myocardium but not by infarct tissue, ExiTron MyoC 8000 enables detection of myocardial infarction even at a very low dose. The signal enhancement in the myocardium of infarcted mice after contrast agent injection was exploited for quantification of infarct size. The values of infarct size obtained from the imaging method were compared with those obtained from histology and showed a significant correlation (R2=0.98). Thus, the developed micro-CT method allows for monitoring of a variety of processes such as cardiac remodeling in longitudinal studies.

scholarly journals Respiratory-gated KES imaging of a rat model of acute lung injury at the Canadian Light Source

2017 ◽  
Vol 24 (3) ◽  
pp. 679-685 ◽  
Author(s):  
P. Deman ◽  
S. Tan ◽  
G. Belev ◽  
N. Samadi ◽  
M. Martinson ◽  
...  
Keyword(s):  
Lung Injury ◽  
Contrast Agent ◽  
Light Source ◽  
Imaging Techniques ◽  
Image Acquisition ◽  
Brown Norway ◽  
Pulmonary Vasculature ◽  
Imaging Method ◽  
Imaging Protocol ◽  
Iodinated Contrast

In this study, contrast-enhanced X-ray tomographic imaging for monitoring and quantifying respiratory disease in preclinical rodent models is proposed. A K-edge imaging method has been developed at the Canadian Light Source to very accurately obtain measurements of the concentration of iodinated contrast agent in the pulmonary vasculature and inhaled xenon in the airspaces of rats. To compare the iodine and xenon concentration maps, a scout projection image was acquired to define the region of interest within the thorax for imaging and to ensure the same locations were imaged in each K-edge subtraction (KES) acquisition. A method for triggering image acquisition based on the real-time measurements of respiration was also developed to obtain images during end expiration when the lungs are stationary, in contrast to other previously published studies that alter the respiration to accommodate the image acquisition. In this study, images were obtained in mechanically ventilated animals using physiological parameters at the iodine K-edge in vivo and at the xenon K-edge post mortem (but still under mechanical ventilation). The imaging techniques were performed in healthy Brown Norway rats and in age-matched littermates that had an induced lung injury to demonstrate feasibility of the imaging procedures and the ability to correlate the lung injury and the quantitative measurements of contrast agent concentrations between the two KES images. The respiratory-gated KES imaging protocol can be easily adapted to image during any respiratory phase and is feasible for imaging disease models with compromised lung function.

Optical Coherence Tomography Angiography in Retinal Diseases

2017 ◽  
pp. 69-74
Keyword(s):  
Optical Coherence Tomography ◽  
Contrast Agent ◽  
Optical Coherence Tomography Angiography ◽  
Imaging Method ◽  
Retinal Diseases ◽  
Optical Coherence ◽  
Vascular Networks ◽  
Motion Contrast ◽  
Choroidal Vasculature

Optical coherence tomography angiography (OCTA) is a new imaging method providing the assessment of retinal and choroidal vasculature without a contrast agent. In this angiography type, the vascular networks have been visualized in detail though detecting motion contrast of erythrocytes in the vessel, using serial optical coherence tomography B-scans. Currently, OCTA findings of many retinal diseases have been reported.

Sign in / Sign up

Export Citation Format

Share Document